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Glutamate is the major excitatory neurotransmitter in the brain. Among the
cognate ionotropic glutamate receptors, the subfamily selective for AMPA
(-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) is responsible for
most fast excitatory synaptic signaling and plays key roles in synaptic plasticity.
AMPA receptors (AMPA-Rs) have also been implicated in a number of neuro-
logical disorders. To investigate subunit-specific differences in the ligand binding
and activation of AMPA-Rs, the GluR4 AMPA-R ligand-binding domain
(LBD) was crystallized in complex with full and partial agonists. This is the first
non-GluR2 AMPA-R LBD available for structural analysis. Standard cryo-
protection protocols yielded high-resolution diffraction from flash-cooled
crystals of the complex with the full agonist glutamate. However, for cocrystals
with the partial agonist kainate, systematic screening and optimization of cryo-
protection conditions yielded at best mosaic, weak diffraction at 100 K. In
contrast, room-temperature data collection from capillary-mounted kainate
cocrystals exhibited reproducible diffraction to better than 3 A˚ resolution.
Together, these crystals lay the foundation for a structural comparison of LBD–
agonist interactions in distinct AMPA-R subunits.
1. Introduction
Glutamate-receptor ion channels are the principal mediators of
excitatory synaptic signals in the central nervous system. They are
classfied into subfamilies based on differential affinities for three
characteristic ligands: -amino-3-hydroxy-5-methyl-4-isoxazole pro-
pionic acid (AMPA), N-methyl-d-aspartic acid and kainic acid (KA).
Of these, the AMPA receptors (AMPA-Rs) are the primary media-
tors of fast synaptic signals between neurons and also participate in
regulating the strength of synaptic connections, a key foundation of
learning and memory. Understanding the detailed mechanisms of
AMPA-R activation and desensitization may thus provide insights
into the stereochemical basis of these fundamental biological pro-
cesses. AMPA-Rs have also been implicated in a number of neuro-
pathologies (Dingledine et al., 1999; Madden, 2002).
AMPA-Rs are assembled from the subunits GluR1–GluR4, usually
as heteromeric combinations of two or more subunits. Although the
subunits share high levels of sequence identity (68–73%), they exhibit
distinct electrophysiological and pharmacological characteristics. As
a result, the subunit-expression pattern of a given neuron can
modulate its glutamatergic response in vivo (Dingledine et al., 1999;
Madden, 2002). Comparison of the stereochemistry of multiple
AMPA-R subunits may help us to understand the basis of these
functional differences and may also provide targets for the devel-
opment of more subunit-specific pharmacological agents (Bra¨uner-
Osborne et al., 2000).
Functional diversity is provided by mechanisms of alternative
splicing and RNA editing of the AMPA-R subunits. One of the most
important modifications involves the RNA editing of a Gln codon to
yield an Arg at a site in the ion-conduction pathway of the GluR2
subunit. AMPA-Rs lacking GluR2 subunits conduct both monovalent
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cations and calcium, whereas AMPA-Rs incorporating GluR2 sub-
units are relatively impermeable to calcium. Both of these forms of
AMPA-Rs are physiologically important (Cull-Candy et al., 2006). In
contrast, homomeric channels composed exclusively of edited GluR2
subunits have very low channel-conductance levels. Thus, while other
AMPA-R subunits can form functional homomeric channels, edited
GluR2 subunits cannot. Furthermore, ER retention mechanisms
ensure that edited GluR2 subunits are not normally trafficked to the
plasma membrane unless they assemble with other subunits to form
heteromeric receptors (Greger & Esteban, 2007).
Despite these unique functional characteristics, GluR2 was the first
iGluR subunit for which the LBD was crystallized (Armstrong et al.,
1998), and structures are now available for dozens of GluR2-LBD–
ligand complexes. However, although crystal structures have since
been determined for multiple members of the other iGluR sub-
families, GluR2 remains the only AMPA-R subunit to be crystallized
to date (Oswald, 2004; Mayer, 2006). The available GluR2 LBD
structures reveal a bilobate structure with an agonist-dependent cleft
closure, the magnitude of which generally varies with the relative
efficacy of the agonist (Madden, 2002). In contrast, analysis of the
LBD of the NR1 subunit of the N-methyl-d-aspartate subfamily
showed no such dependence (Inanobe et al., 2005). Thus, in order to
test the generality of the observations made with the GluR2 LBD, we
have expressed, purified and crystallized the GluR4 LBD in complex
with both a full and a partial agonist. In this report, we identify
conditions that yield well ordered crystals for both protein–ligand
complexes. Our studies also demonstrate the importance of assessing
diffraction quality at room temperature for crystals that resist cryo-
protection.
2. Materials and methods
2.1. Protein expression and purification
The Rattus norvegicus GluR4flip (UniProt accession No. P19493-2;
Sommer et al., 1990) LBD construct was generously provided by
A. Birdsey-Benson. The ‘S1’ and ‘S2’ sequences (residues 393–507
and 633–775 of the mature sequence, respectively) were joined by a
GT linker and subcloned into the pET16b vector (Novagen), which
fused the sequence MGHHHHHHHHHHSSGHIEGRHMLVP-
R#GA, containing a decahistidine tag (bold) and a thrombin cleavage
site (italics; # indicates the site of cleavage), to the N-terminus of the
LBD-coding region and a single Ser residue to the C-terminus. The
accuracy of the construct was verified by DNA sequencing.
XJb(DE3) Autolysis cells were transformed with the GluR4-LBD
vector. 1 l SOC medium (with 3 mM l-arabinose and 100 mg ml1
ampicillin) was inoculated with 5 ml of an overnight culture and
incubated at 310 K. At an OD600 of 0.6, the cells were induced with
0.1 mM isopropyl -d-1-thiogalactopyranoside, grown for 20 h at
293 K and harvested by centrifugation. Cell pellets were resuspended
in 50 ml 20 mM Tris–HCl pH 8.0, 150 mMNaCl, 50 mg ml1 lysozyme,
200 mg ml1 sodium deoxycholate, 25 U ml1 Benzonase (EMD)
containing one Complete EDTA-free tablet (Roche). Cells were
lysed by two freeze–thaw cycles (dry ice with EtOH/310 K water
bath) followed in the case of residual turbidity by one pass through a
French press at 6.9 MPa. The lysate was supplemented with 5 mM
MgSO4 and clarified by ultracentrifugation (45 min, 125 000g, 277 K).
The supernatant was supplemented with 1 mM l-glutamate, 5 mM
l-methionine, 1 mM phenylmethylsulfonyl fluoride and 5 mM
imidazole and loaded onto a Qiagen Ni–NTA Superflow column pre-
equilibrated with IMAC buffer (20 mM Tris–HCl pH 8.0, 150 mM
NaCl, 1 mM sodium glutamate, 5 mM l-methionine) containing
5 mM imidazole. This column was then washed at 90 mM imidazole
and eluted with a 90–400 mM imidazole gradient over eight column
volumes in IMAC buffer. Eluates were pooled, concentrated and
dialyzed in IMAC buffer containing 2 mM EDTA and then in 50 mM
Tris–HCl pH 8.0, 75 mM NaCl, 10 mM CaCl2 at 277 K.
The N-terminal His tag was removed using the Thrombin Clean-
cleave kit (Sigma). Uncleaved protein was captured on a second
metal-affinity column. Cleaved protein flowed through the column
and was then dialyzed extensively (six buffer exchanges for 4 h each
at a volume ratio of 200:1; 1 mg ml1 protein concentration) against
crystallization buffer (10 mM HEPES–NaOH pH 7.0, 30 mM NaCl,
1 mM EDTA). Protein concentrations were determined by Bradford
assay (Bradford, 1976).
2.2. Crystallization
To prepare crystals of the glutamate complex GluR4-LBD–Glu,
protein at 10 mg ml1 was supplemented with l-glutamate to a final
concentration of 10 mM. Crystals were obtained by vapor diffusion
against Hampton Crystal Screen 1 condition No. 20 [25%(w/v)
polyethylene glycol (PEG) 4000, 0.1M sodium acetate pH 4.6, 0.2M
ammonium acetate] at 293 K in sitting drops (100 ml reservoir
volume; 1:1 protein:buffer ratio in a total drop volume of 2 ml).
For crystallization of the kainate complex GluR4-LBD–KA,
purified protein at 7 mg ml1 was supplemented with kainate (Sigma)
to a final concentration of 5 mM. GluR4-LBD–KA crystals grew in
hanging drops (1:1 protein:buffer ratio in a total drop volume of 2 ml)
equilibrated by vapor diffusion at 291 K against 500 ml 24–26%(w/v)
PEG 1500, 50 mM sodium acetate pH 4.5–5.0.
2.3. Crystal harvest and mounting
GluR4-LBD–Glu crystals were soaked in crystallization buffer
supplemented with 10 mM l-glutamate and 14%(w/v) glycerol as
cryoprotectant and flash-cooled by plunging them into a liquid-
nitrogen bath.
For the GluR4-LBD–KA crystals, varying concentrations of
common cryoprotectants (Table 1) were tested for their ability to
support vitrification of the harvest buffers [25–28%(w/v) PEG 1500,
50 mM sodium acetate pH 5.0, 5 mM kainate]. GluR4-LBD–KA
crystals were either transferred directly into the final cryoprotectant
solution or else transferred through increasing concentrations of
cryoprotectant solution before flash-cooling in either liquid nitrogen
or in the nitrogen stream of an Oxford Cryostream 700 at 100 K.
Crystals were mounted for RT data collection in 0.5 mm glass
crystallization communications
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Table 1
Assessment of harvesting and mounting conditions for GluR4-LBD–KA cocrystals.
Condition†
Temperature
(K) Diffraction quality
HS‡ only 100 No spots
HS + 16–20% glycerol 100 No spots
HS + 24% glycerol 100 Few spots, 10–12 A˚ resolution
HS + 6–10% ethylene glycol 100 No spots
HS + 12–28% ethylene glycol 100 Few spots, 6–8 A˚ resolution
HS + 30% sucrose 100 Weak diffraction, 10–12 A˚ resolution
HS + 24% MPD 100 No spots
HS + 25–30% PEG 400 100 Weak diffraction, 8–10 A˚ resolution
HS + perfluoropolyether 100 No spots
HS/capillary† 293 (RT) Strong diffraction, 2.2–3 A˚ resolution
† With the exception of the capillary-mounted crystal, all crystals were harvested in
nylon loops and subjected to flash-cooling. ‡ Harvest solution (HS) corresponds either
to the well solution used for crystallization or to the well solution supplemented with
1–2%(w/v) PEG as a potential stabilizer. For flash-cooling experiments, this was
supplemented with various cryoprotectants at the concentrations listed.
capillaries (Hampton Research) using standard protocols (Rayment,
1985).
2.4. Data collection
Diffraction data were obtained on a MAR345dtb image-plate
system (Rayonix) using Cu K radiation from a rotating-anode
generator (Rigaku) equipped with focusing optics (Genova). Crystals
were screened for diffraction quality using 5–30 min 1 oscillation
images. The GluR4-LBD–Glu data set was collected at 100 K
(Oxford Cryostream 700) over a 180 oscillation range in 2 min 0.5
frames. The GluR4-LBD–KA data set was collected at RTover a 200
oscillation range in 3 min 1 frames.
2.5. Data analysis
The X-ray data sets obtained from GluR4-LBD–Glu and GluR4-
LBD–KA crystals were analyzed using the XDS package (Kabsch,
1993). The CNS suite of programs (Bru¨nger et al., 1998) was used to
perform rotation-function and translation-function searches from 12
to 3 A˚ resolution using the GluR2-LBD–Glu structure (PDB code
1ftj; sequence identity 89%) as the search model after modification
using CHAINSAW to truncate non-identical side chains to the last
common atom (Schwarzenbacher et al., 2004).
3. Results
Here, we present conditions for the expression and purification of the
LBD of the ‘flip’ splice isoform (Sommer et al., 1990) of the GluR4
AMPA-R subunit (GluR4flip). The domain boundaries correspond to
those of the S1S2J construct used previously in most crystallographic
studies of the GluR2 LBD (Armstrong & Gouaux, 2000), which
should facilitate direct comparison across subunits. Following purifi-
cation, thrombin cleavage efficiently removes the polyhistidine tag
(Fig. 1a).
Identification of crystallization conditions for both the glutamate
(Fig. 1b) and kainate (Fig. 1c) complexes of the GluR4-LBD was
straightforward. Glycerol was tested for its ability to support flash-
cooling of the GluR4-LBD–Glu crystallization buffer. 14%(w/v)
glycerol was found to be sufficient and GluR4-LBD–Glu crystals
harvested into the corresponding cryobuffer exhibited excellent
diffraction characteristics. A full data set was obtained on a rotating-
anode source with a resolution limit of 1.85 A˚ (Rmerge = 0.091; see
Table 2).
In contrast, despite the optical quality of the GluR4-LBD–KA
cocrystals, we were unable to identify cryoprotectant conditions that
yielded high-resolution data following flash-cooling. A survey of the
most common cryoprotectants identified several that permitted
vitrification of the harvest buffer at the concentrations shown in
Table 1. Crystals remained optically clear during transfer and
following flash-cooling using both liquid nitrogen and cooled nitrogen
gas. Nevertheless, the resulting diffraction patterns either showed no
spots (26 of 48 crystals tested) or else exhibited blurry low-resolution
diffraction (22 crystals) (Fig. 2a).
Given the simplicity of identifying cryoconditions for other GluR4-
LBD crystals, we suspected that the GluR4-LBD–KA crystals were
inherently disordered. However, to test this hypothesis, we mounted
crystals in glass capillaries. Of 12 crystals, all exhibited diffraction
extending to at least 4 A˚ and ten exhibited diffraction to better than
3 A˚ resolution (Fig. 2b). As a result, we were able to obtain a
complete data set to a resolution of 2.7 A˚ (Rmerge = 0.095; see Table 2).
Molecular-replacement searches carried out with the 1ftj GluR2-
LBD search model yielded unambiguous solutions. Rotation and
translation searches with the GluR4-LBD–Glu data set yielded two
molecules in the asymmetric unit, with a correlation coefficient of
0.67 and a solvent content of 54%. Rotation and translation searches
with the GluR4-LBD–KA data set yielded a single molecule in the
crystallization communications
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Figure 1
Protein purification and crystallization. (a) Silver-stained SDS–PAGE gel on which
purified GluR4-LBD protein is resolved before () and after (+) thrombin
cleavage and chromatographic removal of the polyhistidine tag. The positions of
molecular-weight standards are shown on the left in kDa. Representative crystals
are shown for the GluR4-LBD–Glu (b) and GluR4-LBD–KA (c) complexes. Scale
bars are 25 mm.
Table 2
Crystallographic and data-collection statistics.
Values in parentheses are for the highest resolution shell.
Protein GluR4-LBD GluR4-LBD
Ligand l-Glutamate Kainate
Conditions 100 K, cryocooled RT, capillary mounted
Space group P21 C2
Unit-cell parameters (A˚, ) a = 47.374, b = 105.124,
c = 66.636,  = 97.26
a = 125.91, b = 48.75,
c = 47.77,  = 109.06
Crystal dimensions (mm) 0.13  0.025  0.015 0.17  0.12  0.06
Matthews coefficient (A˚3 Da1) 2.67 2.32
Molecules in ASU (Z) 2 1
Solvent content (%) 53.6 49.4
Resolution (A˚) 19.51–1.85 (1.90–1.85) 11.95–2.7 (2.8–2.7)
Unique reflections 52938 (3988) 7353 (743)
Completeness (%) 96.4 (93.8) 95.6 (96.2)
Rmerge† 0.091 (0.182) 0.095 (0.241)
Mean redundancy 3.82 (3.80) 3.81 (3.84)
Mean I/(I) 11.37 (6.68) 11.14 (5.85)
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ.
asymmetric unit, with a correlation coefficient of 0.73 and a solvent
content of 49%.
4. Discussion
In this study, we have obtained high-resolution diffraction data for
two complexes of the GluR4 AMPA-receptor LBD with full and
partial agonists; this is the first non-GluR2 AMPA-R domain to be
crystallized. We also report successful molecular-replacement solu-
tions that provide the foundation for detailed crystallographic
analysis. The determination of refined structures based on these data
will permit a direct assessment of the extent to which the cleft-closure
mechanism of channel activation, which has proposed for AMPA-Rs
on the basis of GluR2-LBD structures alone, can be generalized to
other subunits. It will also provide insights into the detailed agonist-
binding stereochemistry of these physiologically important neuro-
transmitter receptors.
In the process, we encountered a situation that is not frequently
described in the recent literature: a well ordered crystal for which
systematic optimization of conditions failed to identify a cryo-
protectant regime that preserves the order of the crystal lattice.
Cryocrystallography has become so routine that it is sometimes
assumed that failure to obtain high-resolution diffraction reflects an
inherent lack of lattice order in the crystals, particularly if other
crystals of the same protein have proven amenable to cryocrystallo-
graphy. While we cannot exclude the possibility that further searching
could identify successful cryoprotectant conditions for the GluR4-
LBD–KA cocrystal, at this stage a common strategy would have been
to initiate a search for alternative crystallization conditions. However,
our experience underscores the importance of evaluating room-
temperature diffraction characteristics before discarding cryo-
incompatible crystals. Doing so enabled us to collect a high-resolution
data set for the GluR4-LBD–KA cocrystal. The effort required is
small compared with screening for alternative crystallization condi-
tions, particularly using the novel methods that have been developed
to facilitate capillary mounting (Basavappa et al., 2003; Jeruzalmi,
2007). Thus, room-temperature data collection remains an important
experimental option, despite the current near-ubiquity of cryo-
crystallographic techniques (Garman, 2003; Garman & Owen, 2006).
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